Objective: To investigate whether pregnancy complications are increased in poor responders to ovarian stimulation in IVF treatment.
Introduction
Advanced maternal age is associated with increased obstetric and perinatal complications. The effects of increasing age occur as a continuum, rather than as a threshold effect. There is an increase in the rates of spontaneous early abortions, chromosomal aberrations, and congenital anomalies with ageing (1) . In ongoing pregnancies gestational diabetes, hypertensive disorders and placental problems such as placenta previa and abruption are encountered more often in elderly women (2) . Furthermore, pre-existing maternal diseases such as diabetes mellitus, hypertension, cancer and cardiovascular, renal and autoimmune diseases complicate pregnancy more often in these patients (3) . Perinatal mortality and morbidity of babies born to women of advanced age are also increased. This is partly due to diseases complicating pregnancy. Preterm labor and low birth weight babies and unexplained still birth are increased in elderly gravidas (1, 4) . The question of whether this increased incidence of complications in women of advanced age because of ageing of the organism itself or ageing of the ovarian follicles needs to be investigated. Chronological age of the ovaries is not always equivalent to the biological age. Approximately 10% of the women have a diminished ovarian reserve and accelerated ovarian ageing when compared to their age matched counterparts. Chromosomal abnormalities and abortions are proven to be increased in women with advanced ovarian age in the previous studies (5) (6) (7) . However an impact of ageing of the oocytes on pregnancy complications has not been investigated. In this study we aimed to determine whether pregnancy complications are increased in women with advanced ovarian ageing.
Materials and Methods
This retrospective study was conducted at Baskent University from December 2004 to April 2008. We reviewed the antenatal follow up and birth records of 26 poor responder and 125 normoresponder patients. Twenty six poor responder women who had undertaken IVF/ICSI cycle treatment and were successfully delivered in Baskent University were eligible for this study. Patients from whom less than or equal to 6 oocytes were collected at the oocyte retrieval, which consisted of germinal vesicle and metaphase I, II oocytes, despite a total gonadotrophin dose over 3000 IU used, were defined as poor responders. Oral contraceptive plus microdose flare-up protocol and GnRH Antagonist protocol were performed on all poor responder women. Patients from whom more than 6 oocytes were collected at the oocyte retrieval, which consisted of germinal vesicle and metaphase I, II oocytes, with a gonadotrophin dose of less than 3000 IU used, were defined as normoresponders. Only long GnRH agonist protocol has been performed on normoresponder 125 women. Women whose gestational follow-up and their deliveries were completed at Baskent University were eligible for this study as well. Exclusion criterias of this retrospective study were pregnancies conceived spontaneously, pregnancies after spontaneous and induced embryo reduction, and multiple pregnancies. Multiple pregnancies were excluded to avoid the confounding effect of increased complications attributed to them. According to our clinical approach, long GnRH agonist protocol is the first choice for expected normoresponder patients. In this retrospective analysis, we aimed to distinguish the prenatal outcomes of normoresponder women and poor responder women, who had undertaken the IVF/ICSI program.
Statistical analysis
Data were expressed as means±standard deviation (SD) and analyzed with Student's t test, Chi-square test, and MannWhitney two sample test (unpaired, nonparametric). p<0.05 was considered significant. SPSS for Windows (version 16.0; SPSS, Inc., Chicago, IL) was used for statistical analyses.
Results
Demographic characteristics of the patients are given in Table 1 . A total of 113 (74.8%) patients, of whom 93 (74.4%) were from the normoresponder group and 20 (76.9%) were from the poor responder group, did not have any pregnancy complications. Eighteen patients (14.4%) from the normoresponder group and 3 (11.5%) patients from the poor responder group had gestational diabetes. Seven patients from the normoresponder had placenta previa (5.6%). Two patients from the normoresponder (1.6%) group had pregnancy induced hypertension. Two patients (1.6%) from the normoresponder group had preeclampsia. One patient from each group had fetal anomaly (3.8% for poor responders vs. 0.8% for normoresponders). Two patients from the normoresponder (1.6%) group had cholestasis. Two patients from the poor responder group were delivered prematurely (7.6%). There was no preterm labor in the normoresponder group.
Discussion
Our results revealed that pregnancy complications were not increased in patients with a reduced ovarian reserve when compared to their age matched counterparts. More than two thirds of the patients had uneventful pregnancies. Gestational diabetes was the most common disease complicating pregnancy. Incidence was similar in both the study and control groups (14.4 vs. 11.8%). In the literature the incidence of gestational diabetes varies between 1.4% and 14% depending on the characteristics of the population studied and the screening method (8) . Placenta previa was the second most common complication. Romunstad et al. compared the pregnancies which are conceived spontaneously and via ART in the same mother and reported a three fold increase in placenta previa in IVF pregnancies (9) . The incidences of pregnancy induced hypertension and preeclampsia in both groups were somewhat lower than the expected rates of 6% for gestational hypertension (10) and 12-22% for preeclampsia (11). This may be explained by the small size of the groups, mean age of the groups or the singleton pregnancies selected for the study. Preeclampsia is more common in women below 18 and over 35 years of age and in multiple pregnancies. The mean age of the patients was 30.6 years and 32.5 years for normoresponders and poor responders respectively, which may have contributed to the low incidence of hypertensive diseases. The major congenital anomaly rate is reported to be 2.91%. In this study it was lower than the expected rate for the normoresponder group. However, this may be due to the small sample size. Two patients from the normoresponder (1.6%) group had cholestasis. The incidence of intrahepatic cholestasis of pregnancy is reported to be 0.1-15.6% (12) . The incidence of prematurity was 7.7% for the normoresponders (Table2). This is lower than the incidence of 13.8%-14.1% reported in the literature (13) . In conclusion, the biological age of the organism seems to determine the outcome of pregnancy. Currently there are no studies on the effects of ovarian ageing on pregnancy in patients aged <35 years. However, there have been some studies on pregnancy outcomes in patients aged ≥35 years and receiving young donor oocytes. Excellent pregnancy outcomes are reported in these pregnancies (14, 15 pregnancies of women older than 45 years who had pregnancies from an oocyte donation cycle with spontaneous pregnancies of women younger than 36 years old. The gamete age was similar in both groups. They reported that mature women over 45 years conceiving largely through ART with donor eggs can expect newborn outcomes similar to younger women cared for in the same setting of a high-risk maternal-fetal practice (16) . Because IVF pregnancies themselves are already at high risk for perinatal complications, we included IVF patients into both the study and the control groups. The limitation of this study is the small size of the poor responder group. In our center, 12.7% of the ART cycles were the poor responder's cycles, which is consistent with the literature. In fact, it has been reported to be 9-26% (17) . The low rate of pregnancy, the live birth rate and the high miscarriage rate in poor responder patients may be due to the poor quality of oocytes. Because of the high abortion rates in poor responders, the number of women reaching the first trimester screening is fewer. Besides, only the pregnant women who would have singleton babies were enrolled to avoid the possible confounding effect of multifetal pregnancy on serum markers. Our center is also a reference center to which patients from the neighboring cities present for ART. In addition, most of the patients, when they become pregnant, return home where they attend antenatal care and deliver. For these reasons, a high number of the scheduled poor responder patients did not come to the first trimester screening. Therefore, data of only 26 poor response patients screened in the first trimester were available. All the above mentioned factors caused a small size of the poor responders. This study may be considered a pilot study and a larger study can yield more accurate results. 
